Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lisata Therapeutics (GB:0HS8)
LSE:0HS8
Holding GB:0HS8?
Track your performance easily
0HS8 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.03 - $3.74
Previous Close$2.96
Volume125.00
Average Volume (3M)591.00
Market Cap
$24.54M
Enterprise Value-$13.97M
Total Cash (Recent Filing)$38.26M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.26
Next Earnings
Nov 07, 2024EPS Estimate
-$0.75Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.56
Shares Outstanding8,319,600
10 Day Avg. Volume230
30 Day Avg. Volume591
Standard Deviation0.16
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.64
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.81
Forecast
1Y Price Target
$15.00Price Target Upside406.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Lisata Therapeutics News
0HS8 FAQ
What was Lisata Therapeutics’s price range in the past 12 months?
Lisata Therapeutics lowest share price was $2.03 and its highest was $3.74 in the past 12 months.
What is Lisata Therapeutics’s market cap?
Currently, no data Available
When is Lisata Therapeutics’s upcoming earnings report date?
Lisata Therapeutics’s upcoming earnings report date is Nov 07, 2024 which is in 49 days.
How were Lisata Therapeutics’s earnings last quarter?
Lisata Therapeutics released its earnings results on Aug 12, 2024. The company reported -$0.61 earnings per share for the quarter, beating the consensus estimate of -$0.75 by $0.14.
Is Lisata Therapeutics overvalued?
According to Wall Street analysts Lisata Therapeutics’s price is currently Undervalued.
Does Lisata Therapeutics pay dividends?
Lisata Therapeutics does not currently pay dividends.
What is Lisata Therapeutics’s EPS estimate?
Lisata Therapeutics’s EPS estimate is -$0.75.
How many shares outstanding does Lisata Therapeutics have?
Lisata Therapeutics has 8,319,600 shares outstanding.
What happened to Lisata Therapeutics’s price movement after its last earnings report?
Lisata Therapeutics reported an EPS of -$0.61 in its last earnings report, beating expectations of -$0.75. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Lisata Therapeutics?
Among the largest hedge funds holding Lisata Therapeutics’s share is RA Capital Management. It holds Lisata Therapeutics’s shares valued at N/A.
---
Lisata Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.00 (406.76% Upside)
$15.00 (406.76% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
47.50%
12-Months-Change
Fundamentals
Return on Equity
-43.80%
Trailing 12-Months
Asset Growth
-31.74%
Trailing 12-Months
Company Description
Lisata Therapeutics
Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in developing products in cardiovascular and autoimmune disease that have the potential to restore the health of people with chronic illnesses. Its product pipeline includes CLBS12, CLBS14, and CLBS03. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.
---
0HS8 Company Deck
---
0HS8 Earnings Call
Q2 2024
0:00 / 0:00
---
0HS8 Stock 12 Month Forecast
Average Price Target
$15.00
▲(406.76% Upside)
Technical Analysis
Lisata Therapeutics
―
Cellectar Biosciences
―
Plus Therapeutics
―
Aditxt, Inc.
―
Microbot Medical
―
Best Analysts Covering 0HS8
1 Year
1 Year Success Rate
7/14 ratings generated profit
1 Year Average Return
+5.89%
reiterated a buy rating 2 days ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +5.89% per trade.
---